| Patents for C07B 53 - Asymmetric syntheses (6,231) |
|---|
| 08/31/2005 | EP1483276B1 Ferrocenyl ligands and the use thereof in catalysis |
| 08/31/2005 | EP1363516B1 An improved process for preparing simvastatin |
| 08/31/2005 | CN1662520A Process for the preaparation of dioxane acetic acid esters |
| 08/31/2005 | CN1662484A Process for preparing (r)-aryloxypropionic acid ester derivatives |
| 08/31/2005 | CN1660818A Process for the manufacture of organic compounds |
| 08/25/2005 | WO2005077921A1 Guanidine compound and asymmetric reaction using the same |
| 08/25/2005 | WO2005077908A1 Guanidine compound and asymmetric reaction using the same |
| 08/25/2005 | WO2005077871A1 Method for producing optically active alcohols or carboxylic acids |
| 08/25/2005 | WO2005077870A1 Hydrogenation method for producing optically active alcohols or carboxylic acids |
| 08/25/2005 | US20050187392 Hydrolytic kinetic resolution of cyclic substrates |
| 08/25/2005 | CA2553700A1 Hydrogenation method for producing optically active alcohols or carboxylic acids |
| 08/25/2005 | CA2553249A1 Method for producing optically active alcohols or carboxylic acids |
| 08/24/2005 | CN1659178A 6, 11 bicyclic erythromycin derivatives |
| 08/24/2005 | CN1659154A Method of preparing amine stereoisomers |
| 08/24/2005 | CN1659147A Pyridazine derivatives |
| 08/24/2005 | CN1659135A Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia |
| 08/24/2005 | CN1216036C Chiral alkamine ligand and its application in asymmetrical addition of terminal alkyne para imine |
| 08/18/2005 | WO2005075074A1 Inorganic solids, such as porous and particularly mesoporous inorganic solids, which are modified by transition metal-chelating organic molecules, preparation method thereof and use of same as catalysts |
| 08/18/2005 | WO2005075073A1 Water-soluble transition metal-diamine complex and use thereof |
| 08/18/2005 | US20050182112 3-[4-(3,6-dihydro-2H-thiopyran-4-yl) phenyl]-]5[1H or 2H-1,2,3-triazol-1 or 2-yl] oxazolidin-2-ones; grampositive bactericides for drug resistant bacteria, especially Staphylococcus, Enterococcus, and Streptococcus |
| 08/18/2005 | US20050182070 Method for the treatment of allergic conditions |
| 08/18/2005 | US20050182069 For treatment of asthma, allergies, inflammation and anxiety; antihistamines; sedatives; tranquilizing agents; 2[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetamide |
| 08/17/2005 | CN1656077A Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors |
| 08/17/2005 | CN1656047A Process for the preparation of enantiomerically enriched compounds |
| 08/17/2005 | CN1215091C Osmium oxide deposited on hydrophilic polymer support |
| 08/16/2005 | US6930189 Chiral ligand |
| 08/16/2005 | US6930083 Isomer composition excellent in odor and in chemical resistance, which is applicable to a base material containing a strongly alkaline chemical or a strongly acidic chemical, which can suppress the deterioration with time and the color |
| 08/16/2005 | CA2309449C Esters with musky odor and their use in perfumery |
| 08/11/2005 | WO2005073156A1 Process for production of optically active hydroxymethylated compounds |
| 08/11/2005 | WO2005012209A3 Catalyzed enantioselective transformation of alkenes |
| 08/11/2005 | US20050176962 Aminating a -cyanophenylalanine derivative with hydroxylamine hydrochloride in the presence of sodium carbonate in alcoholic-aqueous solution at reflux temperature to a 3-amidino derivative; chemical intermediates as highly efficient urokinase inhibitors |
| 08/11/2005 | US20050176758 2-(hydroxy or methoxymethoxy)-4-(carboxy or alkoxycarbonyl)-5-(fluoro or hydrogen)-7-oxabicyclo(4.1.0)hept-3-ene chemical intermediates to neuraminidase inhibitors |
| 08/11/2005 | US20050176732 Enantiomers of 1-(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine |
| 08/11/2005 | US20050176714 Pyridazine derivatives |
| 08/10/2005 | EP1560649A1 Active catalysts for stereoselective ring-opening reactions |
| 08/10/2005 | CN1653064A Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them |
| 08/10/2005 | CN1213991C Process for the cis-selective catalytic hydrogenation of cyclohexylidenamines |
| 08/09/2005 | CA2093084C Ferrocenyl diphosphines as ligands for homogeneous catalysts |
| 08/04/2005 | WO2005070876A1 METHOD OF ENANTHIO-SELECTIVE NUCLEOPHILIC ADDITION REACTION FOR CONVERSION OF ENAMIDE TO IMINE AND METHOD OF SYNTHESIZING α-AMINO-Ϝ-KETO ACID ESTER |
| 08/04/2005 | US20050171360 Preparation of n-methyl-3-hydroxy- 3-(2-thienyl)propylamine via novel thiophene derivatives containing carbamate groups as intermediates |
| 08/04/2005 | US20050171120 At the 1-position with an alkyl or aryl 1-(4-trifluoromethylphenyl)-2-methoxyethyl sulfonate, deprotecting; coupling methyl 4-trifluoromethylbenzoate with methyl methoxyacetate, hydrolyzing to form 4-trifluoromethyl methoxyacetophenone; 2-methyl-4-trifluoromethylcarbonyl-piperazine; CCR5 antagonists |
| 08/03/2005 | EP1558384A1 Mixtures of chiral monophosphorus compounds used as ligand systems for asymmetric transition metal catalysis |
| 08/03/2005 | EP1499625B1 Ferrocenyl ligands and method for the production of such ligands |
| 08/03/2005 | CN1649891A Improved synthesis of cyproterone acetate |
| 08/03/2005 | CN1213044C Amine and amide derivatives as ligands for neuropeptide YY5 receptor useful in treatment of obesity and other disorders |
| 08/03/2005 | CN1213020C Phenylalaninol derivatives |
| 07/28/2005 | US20050165240 Chemical intermediates for production of sibutramine |
| 07/28/2005 | US20050165108 reacting D-phenylalanine methylester HCl with trans-4-isopropylcyclohexane carboxylic acid in presence of propane phosphonic acid anhydride or LiOH Al2O3 in a halogenated hydrocarbon solvent such as dichloromethane or dichloroethane; type 2 diabetes mellitus |
| 07/28/2005 | US20050165078 evolution of ammonia is virtually completely avoided; reduction in sublimation of urea, as occurs on reaction in the melt; high purity of the crude product means that further recrystallization is usually unnecessary |
| 07/28/2005 | US20050165008 7-chloro-4-(2-fluoroethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide; AMPA (alpha -amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid)modulators; antidepressant, anxiolytic agent |
| 07/28/2005 | US20050164869 Practical chiral zirconium catalyst |
| 07/27/2005 | EP1557412A1 Fluorinated benzothiadiazine derivatives and their use as AMPA receptor modulators |
| 07/27/2005 | EP1556390A2 Functionalized ionic liquids, and methods of use thereof |
| 07/27/2005 | EP1414384A4 Synthesis of epothilones and relates analogs |
| 07/27/2005 | EP1390359B1 Synthesis of cannabinoids |
| 07/27/2005 | CN1646547A Bisphosphines as bidentate ligands |
| 07/27/2005 | CN1646540A Functionalized ionic liquids, and methods of use thereof |
| 07/27/2005 | CN1646487A Preparation of 2-oxethyl-3-[4-(2-{methylsulfonyloxyphen}oxethyl)phenyl] propanoic acid |
| 07/27/2005 | CN1646460A 2-(2, 6-dichlorophenyl)-diarylimidazoles |
| 07/26/2005 | US6921822 Reduction of the corresponding ketone compound using ruthenium catalyst |
| 07/26/2005 | CA2131571C Bisphosphines for asymmetric hydrogenation catalysts |
| 07/21/2005 | US20050158631 Ionic compounds with a delocalized anionic charge, and their use as ion conducting components or as catalysts |
| 07/20/2005 | EP1554295A1 Preparation of partially hydrogenated rac-ansa-metallocene complexes |
| 07/20/2005 | EP1210305B1 Transfer hydrogenation process |
| 07/20/2005 | EP0894087B1 Method for obtaining pure enantiomers of a pyridazinone derivative |
| 07/20/2005 | CN1642937A Process for making chiral 1, 4-disubstituted piperazines |
| 07/20/2005 | CN1642930A Stereoselective alkylation of chiral 2-methyl-4-protected piperazines |
| 07/19/2005 | US6919456 For the direct catalytic asymmetric aldol reaction of aldehydes with donor molecules selected from ketones and nitroalkyl compounds |
| 07/19/2005 | US6919451 Synthesis of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones |
| 07/14/2005 | US20050154225 controlling reaction speed, reactant supply, product withdrawal and separation; ruthenium-biaryl bisphosphine catalysts give high enantiomeric excesses; for commercial manufacture of intermediate compounds to make Statin drugs |
| 07/14/2005 | US20050154224 Enantioselective catalytic hydrogenation and subsequent cyanation suitable for industrial scale; chemical intermediates for antilipemic agents |
| 07/13/2005 | EP1553073A1 Process for production of 1,2,4-butanetriol |
| 07/13/2005 | CN1639147A Synthesis of 4, 5-dihydro-pyrazolo [3, 4-c] pyrid-2-ones |
| 07/13/2005 | CN1639142A Method for producing 3-amidinophenylalanine derivatives |
| 07/13/2005 | CN1639127A Process for asymmetric hydrogenation of hexahydroquinoline salts |
| 07/13/2005 | CN1210253C Asymmetric synthesis (S)-(+)-3-(aminomethyl)-5-methylhexanoic |
| 07/07/2005 | US20050148776 Process for asymmetric hydrogenation of hexahydroquinoline salts |
| 07/07/2005 | US20050148672 reacting methyl bromide and 2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-(trifluoromethyl) phenol; formation of (3R)-3-[2-hydroxy-5-(trifluoromethyl)phenyl]-N,N-diisopropyl-N-methyl-3-phenylpropan-1-aminium bromide; asthma, chronic obstructive pulmonary disorder, allergic and infectious rhinitis |
| 07/06/2005 | EP1485357B1 Process for asymmetric hydrogenation of hexahydroquinoline salts |
| 07/06/2005 | CN1209342C Process of preparing tolterodine and analogues thereof as well as intermediates prepared in the process |
| 06/30/2005 | WO2005058917A2 New oxazoline ligands for asymmetric catalysis |
| 06/30/2005 | WO2005058805A1 Process for producing optically active amine compound |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/29/2005 | EP1545772A2 Nitrogen-containing ligands |
| 06/23/2005 | WO2005056609A1 Cationic oligomer of a saccharide for resolving enantiomers and asymmetric synthesis |
| 06/23/2005 | WO2005056526A1 Intermediates for the production of optically active cyclopropylamine derivatives and process for the production of the intermediates |
| 06/23/2005 | US20050137403 New oxazoline ligands for asymmetric catalysis |
| 06/23/2005 | DE10355066A1 Verfahren zur asymmetrischen Synthese Asymmetric synthesis process |
| 06/22/2005 | CN1630555A Hydroxylation of beta-dicarbonyls with zirconium catalysts |
| 06/21/2005 | US6908935 Calcium receptor modulating agents |
| 06/16/2005 | WO2005021562A3 Phospinite-imidazolines and metal complexes thereof |
| 06/16/2005 | DE10201464B4 Verfahren zur Herstellung reiner Thioctsäure A process for the preparation of pure thioctic acid |
| 06/15/2005 | EP1341797A4 Ortho substituted chiral phosphines and phosphinites and their use in asymmetric catayltic reactions |
| 06/15/2005 | CN1626501A Process for preparing optically active nitro compounds and cyano compounds |
| 06/15/2005 | CN1626492A Hydrogenant process |
| 06/14/2005 | US6906210 Method for producing lipoic acid and dihydrolipoic acid |
| 06/14/2005 | US6906197 Process for the preparation of optically active amines or salts thereof |
| 06/09/2005 | WO2005051964A1 Method for asymmetric synthesis |
| 06/09/2005 | US20050124830 Non-C2-symmetric bisphosphine ligands as catalysts for asymmetric hydrogenation |
| 06/09/2005 | US20050124641 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors |